Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Eastern Cooperative Oncology Group
Colorado State University
Washington University School of Medicine
Fudan University
University Health Network, Toronto
Dana-Farber Cancer Institute
University of Miami
Brigham and Women's Hospital
University of Utah
UNC Lineberger Comprehensive Cancer Center
Duke University
Columbia University
Medical University of Gdansk
Zhongnan Hospital
First Ascent Biomedical Inc.
AC Camargo Cancer Center
University of Nebraska
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center
Mayo Clinic
Memorial Sloan Kettering Cancer Center
University Hospital, Montpellier
Brno University Hospital
University Hospital, Angers
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Dana-Farber Cancer Institute
Rigshospitalet, Denmark
University of Nebraska
Northwestern University
Memorial Sloan Kettering Cancer Center
UNC Lineberger Comprehensive Cancer Center
Hebei Senlang Biotechnology Inc., Ltd.
Azienda USL Reggio Emilia - IRCCS
Centre Hospitalier Universitaire Dijon
University Health Network, Toronto
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Centre Leon Berard
Hospices Civils de Lyon
RenJi Hospital
Shanxi Bethune Hospital
Biogipuzkoa Health Research Institute
University of Toronto
University Hospital Muenster
Alberta Health Services, Calgary
University Medical Center Groningen
Massachusetts General Hospital
Institut de cancérologie Strasbourg Europe
McGill University
Norwegian School of Sport Sciences